Nisa Investment Advisors LLC decreased its position in West Pharmaceutical Services, Inc. (NYSE:WST) by 4.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,290 shares of the medical instruments supplier’s stock after selling 3,560 shares during the period. Nisa Investment Advisors LLC’s holdings in West Pharmaceutical Services were worth $7,161,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in WST. Cambridge Investment Research Advisors Inc. raised its position in West Pharmaceutical Services by 1.6% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock worth $210,000 after buying an additional 40 shares in the last quarter. Private Advisor Group LLC increased its stake in West Pharmaceutical Services by 3.2% in the first quarter. Private Advisor Group LLC now owns 2,899 shares of the medical instruments supplier’s stock worth $232,000 after buying an additional 91 shares during the last quarter. PNC Financial Services Group Inc. increased its stake in West Pharmaceutical Services by 2.6% in the first quarter. PNC Financial Services Group Inc. now owns 6,806 shares of the medical instruments supplier’s stock worth $556,000 after buying an additional 175 shares during the last quarter. Capstone Asset Management Co. increased its stake in West Pharmaceutical Services by 2.4% in the first quarter. Capstone Asset Management Co. now owns 10,160 shares of the medical instruments supplier’s stock worth $829,000 after buying an additional 234 shares during the last quarter. Finally, Advantus Capital Management Inc increased its stake in West Pharmaceutical Services by 3.1% in the first quarter. Advantus Capital Management Inc now owns 9,380 shares of the medical instruments supplier’s stock worth $766,000 after buying an additional 285 shares during the last quarter. 91.12% of the stock is currently owned by institutional investors and hedge funds.
West Pharmaceutical Services, Inc. (NYSE:WST) traded up 0.26% during midday trading on Thursday, reaching $94.28. 7,097 shares of the company traded hands. The stock’s 50 day moving average is $95.99 and its 200 day moving average is $88.37. The company has a market capitalization of $6.93 billion, a price-to-earnings ratio of 39.02 and a beta of 1.12. West Pharmaceutical Services, Inc. has a one year low of $70.17 and a one year high of $99.91.
West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings data on Thursday, April 27th. The medical instruments supplier reported $0.81 earnings per share for the quarter, beating analysts’ consensus estimates of $0.55 by $0.26. The firm had revenue of $387.70 million during the quarter, compared to analyst estimates of $380.42 million. West Pharmaceutical Services had a return on equity of 14.89% and a net margin of 11.88%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.53 earnings per share. On average, equities analysts anticipate that West Pharmaceutical Services, Inc. will post $2.73 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 2nd. Stockholders of record on Wednesday, July 19th will be paid a dividend of $0.13 per share. This represents a $0.52 dividend on an annualized basis and a dividend yield of 0.55%. The ex-dividend date of this dividend is Monday, July 17th. West Pharmaceutical Services’s dividend payout ratio (DPR) is presently 21.40%.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://stocknewstimes.com/2017/07/20/nisa-investment-advisors-llc-sells-3560-shares-of-west-pharmaceutical-services-inc-nysewst.html.
A number of research firms have recently weighed in on WST. Jefferies Group LLC restated a “hold” rating and issued a $90.00 price target on shares of West Pharmaceutical Services in a research note on Thursday, June 8th. Zacks Investment Research upgraded shares of West Pharmaceutical Services from a “hold” rating to a “strong-buy” rating and set a $114.00 price target on the stock in a research note on Friday, June 9th. Finally, BidaskClub downgraded shares of West Pharmaceutical Services from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 13th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company’s stock. West Pharmaceutical Services presently has a consensus rating of “Hold” and a consensus price target of $90.18.
In other news, VP Daniel Malone sold 4,124 shares of the stock in a transaction that occurred on Tuesday, May 2nd. The stock was sold at an average price of $93.31, for a total transaction of $384,810.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO William J. Federici sold 54,996 shares of the stock in a transaction that occurred on Thursday, May 18th. The shares were sold at an average price of $95.45, for a total value of $5,249,368.20. The disclosure for this sale can be found here. Corporate insiders own 1.90% of the company’s stock.
West Pharmaceutical Services Company Profile
West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).
Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
